Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2060.05

-66.95 (-3.15%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2060.05

-66.95 (-3.15%)
15:33 Dec 20

Quality

0/100
Not Eligible

Valuation

6/100
Expensive Valuation

Technical

67/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Net Sales	90.81	116.12	183.84	227.11	295.71
Operating Expenses +	72.89	91.38	141.14	173.99	235.72
Raw Material	45.21	60.55	96.21	110.4	167.65
Increase Decrease in Cost	-0.85	-1.77	-1.75	-4.71	-18.24
Other Manufacturing Expense	10.33	13.4	17.78	24.29	31.79
Employee Cost	9.46	10.88	15.91	22.7	25.89
Miscellaneous Expenses	8.74	8.32	12.99	21.31	28.63
Operating Profit	17.92	24.74	42.7	53.12	59.99
Other Income	0.41	0.5	0.76	0.75	1.36
Depreciation	3.76	6.87	7.25	10.41	9.78
Interest	2.59	2.42	1.9	2.41	2.82
Profit before tax and exceptio..	11.97	15.95	34.3	41.06	48.75
Exceptional Items	0	0	0	0	0
PBT	11.97	15.95	34.3	41.06	48.75
Provision for Taxation	2.56	4.23	9.47	10.34	12.32
Net Profit	9.42	11.72	24.83	30.72	36.44
NET Profit after MI	9.42	11.72	24.83	30.72	36.44
EPS	9.93	12.2	25.82	31.95	37.9
Operating Profit Margin (%)	19.73	21.31	23.23	23.39	20.29
Net Profit Margin (%)	10.37	10.09	13.51	13.53	12.32

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	66.70	66.70	66.70	66.70	66.70
FII	1.20	0.90	0.30	0.30	0.30
MF	0.00	0.00	0.00	0.00	0.00
Public	32.00	32.20	32.90	33.00	32.90
Others	0.00	0.10	0.00	0.00	0.10
Others	0.10	0.10	0.10	0.00	0.00